drugset / Trial / NCT06757868
Amobarbital and Cardiopulmonary Bypass
RandomizedParallel-groupDouble-blindTreatment
Summary
Explore the effects of amobarbital on myocardial protection and prognosis in patients undergoing cardiac surgery with cardiopulmonary bypass, investigate the new usage of old drugs, and provide reliable clinical scientific basis for its potential value in better clinical treatment.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2026-04-30
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amobarbital | Small molecule | 1 mg/kg | — |
| Comparator | Midazolam | Small molecule | 0.1 mg/kg | — |
Indications
No indication recorded.